Featured Jobs
|
Relationship Manager for Defined Benefits Daybright Financial
|
|
Senior ERISA Compliance Analyst Employee Fiduciary, LLC
|
|
Daybright Financial
|
|
Retirement Plan Installation & Document Manager Fringe Benefit Group
|
|
July Business Services
|
|
MAP Retirement
|
|
Defined Contribution Account Manager Nova 401(k) Associates
|
|
Relationship Manager for Defined Contributions Daybright Financial
|
|
Senior Counsel - Benefits and Total Rewards Tyson Foods
|
|
EPIC RPS
|
|
Heller Pension Associates, Inc.
|
|
Executive Assistant / Sales Support M2B Retirement Consulting LLC
|
|
Retirement Compliance Consultant Navia Benefit Solutions
|
Free Publications
|
|
Novo, Lilly to Sell Obesity Drugs Directly to Employers
Seeking Alpha; login may be required 
Nov. 21, 2025 "Starting from Jan. 1, the pharma giants will offer their obesity drugs Wegovy and Zepbound through Waltz Health, a digital health company focused on helping employers buy affordable medications. Under the offering, employers will procure the injectables by paying upfront, fixed prices without involving rebates and fees, which are usually paid to PBMs as part of traditional drug purchases." MORE >> |
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
| An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |